Deep vein thrombosis (DVT) and pulmonary embolism (PE) are two of the most common, dangerous types of blood clots. Here's ...

Thrombosis, or blood clot formation, can be life-threatening if ignored. Learn about its causes, early warning signs, and ...

Three critical recommendations from a national workshop have been released to address deep-vein thrombosis and pulmonary embolism, a growing public health problem estimated to affect nearly 1 million ...

Pulmonary embolism (PE) is a common and potentially life threatening condition that doctors categorize as acute, subacute, or chronic. Deep vein thrombosis can increase a person’s risk of any type of ...

Functional impairment (FI) after hematopoietic cell transplantation (HCT) and impact on quality of life (QOL). Bupropion for hot flashes control in breast cancer survivors: A prospective, double-blind ...

A retrospective, observational, parallel, comparative cohort study was conducted using the PharMetrics Patient-Centric Database, which is comprised of fully adjudicated medical and pharmaceutical ...

Ask a Black Doctor: Pulmonary Embolism Explained was featured in the January/February 2022 issue of ESSENCE — on newsstands now. Rachel Marie Bond, M.D.: You can get a blood clot if you have certain ...

DVT prophylaxis reduces the risk of developing deep vein thrombosis through medications, compression stockings, and devices. Deep vein thrombosis (DVT) can occur when a blood clot forms in a deep vein ...

DVT and PE are collectively referred to as venous thromboembolism (VTE), which is the third most common cardiovascular disorder after coronary artery disease and stroke. A DVT occurs when a blood clot ...

A new review provides an in-depth analysis of the risk of venous thromboembolism (VTE) in patients hospitalized for COVID-19. While hospitalized patients at general wards have a VTE risk of between 5 ...

The FDA has approved a supplemental new drug application for apixaban, an oral selective Factor Xa inhibitor, for the treatment of deep vein thrombosis and pulmonary embolism, as well as for reduction ...

Am J Health Syst Pharm. 2006;63(20):S5-S15. Patient demographics and pre-index clinical characteristics were similar between the subgroups of patients who developed DVT/PE ( Table 1). The average age ...